Open Access6ER-013 Analysis of biological treatments as possible therapeutic alternatives in refractory anti-tnf patients in crohn’s disease
Author(s) -
MC Donoso-Rengifo,
J Lopez-Santamaria,
M Murillo-Izquierdo,
Jaime Ramos,
L Rendon-Lope,
E Alegre
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.506
Subject(s) - ustekinumab , vedolizumab , medicine , clinical endpoint , refractory (planetary science) , crohn's disease , maintenance therapy , placebo , population , phases of clinical research , adalimumab , clinical trial , gastroenterology , surgery , disease , chemotherapy , pathology , physics , environmental health , astrobiology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom